About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Registry of CytoSorb Therapy in COVID-19 ICU Patients

Registry of CytoSorb Therapy in COVID-19 ICU Patients

NCT04391920·7 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

CytoSorbents, Inc

With

CytoSorbents Europe GmbH

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

1. Confirmed COVID-19
2. Provision of CytoSorb therapy per Instructions for Use (IFU) of the CytoSorb device.

You may not be if

1. CytoSorb therapy for diseases other than COVID-19
2. Survival unlikely within 24 hours (for prospectively enrolled patients)

The record

StatusCompleted

PhaseNo phase

Taking part138

StartedAug 2020

UpdatedFeb 9, 2024

Conditions

Where7

Medical Center of Aurora
Aurora, Colorado, United States
University of Chicago Medicine
Chicago, Illinois, United States
Franciscan Health Indianapolis
Indianapolis, Indiana, United States